Brazil's Anvisa seizes counterfeit botulinum toxin batch, bans sale and use

Brazil's health regulator Anvisa ordered seizure of a counterfeit batch of botulinum toxin, prohibiting sale, distribution, or use. The action follows detection of a fake product in the market, posing potential health risks. The scope of distribution and any reported adverse effects remain unclear.

AI disclosure: Model-written summary of the source, not a verified fact. Check the sources. How Mosaic works